Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 22, 363–364 (1 April 2004) | doi:10.1038/nbt0404-363
Erbitux diagnostic latest adjunct to cancer therapy
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
